News stories about Pro-Dex (NASDAQ:PDEX) have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pro-Dex earned a coverage optimism score of 0.22 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 48.2102084988837 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Shares of Pro-Dex (PDEX) traded up $0.15 on Friday, hitting $7.00. The stock had a trading volume of 11,889 shares, compared to its average volume of 9,156. The stock has a market cap of $30.75, a PE ratio of 12.28 and a beta of -0.33. Pro-Dex has a fifty-two week low of $4.30 and a fifty-two week high of $8.00.
WARNING: This article was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3254073/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-pro-dex-pdex-stock-price.html.
Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.